Sign in
Back
Systemic 5-fluorouracil producing an inflammatory response in porokeratosis
Journal article

Systemic 5-fluorouracil producing an inflammatory response in porokeratosis

W K Nahm, K G Donohue, J F Danahy, E Badiavas and V Falanga
Journal of the European Academy of Dermatology and Venereology, Vol.17(2), pp.190-192
2003-03
DOI: https://doi.org/10.1046/j.1468-3083.2003.00575.x
PMID: 12705749

Abstract

Fluorouracil - administration & dosage Administration, Oral Humans Female Aged Breast Neoplasms - drug therapy Porokeratosis - drug therapy Antimetabolites, Antineoplastic - administration & dosage
Topical 5-fluorouracil has been used as an effective treatment for porokeratosis. Upon its treatment, an inflammatory effect occurs with the topical 5-fluorouracil. We report a case of a patient with disseminated superficial actinic porokeratosis displaying a comparable inflammatory process following therapy with systemic 5-fluorouracil used to manage a metastatic breast cancer.

Metrics

7 Record Views
8 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.158 Dermatology - General
1.158.2138 Porokeratosis
Web Of Science research areas
Dermatology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details